Control Bionics (ASX:CBL) Total Assets: A$9.93 Mil (As of Dec. 2025)


What is Control Bionics Total Assets?

Control Bionics ASX:CBL -5.13% Total Assets is A$9.93 Mil as of Dec. 2025. The stock has 6 warning signs investors should review.

Control Bionics's Total Assets for the quarter that ended in Dec. 2025 was A$9.93 Mil.

During the past 12 months, Control Bionics's average Total Assets Growth Rate was -12.60% per year. During the past 3 years, the average Total Assets Growth Rate was -2.40% per year. During the past 5 years, the average Total Assets Growth Rate was 9.30% per year.

During the past 6 years, Control Bionics's highest 3-Year average Total Assets Growth Rate was 16.40%. The lowest was -2.40%. And the median was 11.50%.

Total Assets is connected with ROA %. Control Bionics's annualized ROA % for the quarter that ended in Dec. 2025 was -79.47%. Total Assets is also linked to Revenue through Asset Turnover. Control Bionics's Asset Turnover for the quarter that ended in Dec. 2025 was 0.30.

Control Bionics  (ASX:CBL) Total Assets Explanation

Total Assets is connected with ROA %.

Control Bionics's annualized ROA % for the quarter that ended in Dec. 2025 is

ROA %=Net Income (Q: Dec. 2025 )/( (Total Assets (Q: Jun. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=-7.218/( (8.233+9.933)/ 2 )
=-7.218/9.083
=-79.47 %

Note: The Net Income data used here is two times the semi-annual (Dec. 2025) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Control Bionics's Asset Turnover for the quarter that ended in Dec. 2025 is

Asset Turnover
=Revenue (Q: Dec. 2025 )/( (Total Assets (Q: Jun. 2025 )+Total Assets (Q: Dec. 2025 ))/ count )
=2.76/( (8.233+9.933)/ 2 )
=2.76/9.083
=0.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Control Bionics Total Assets Related Terms

Control Bionics Total Assets Historical Data

* Premium members only.

The historical data trend for Control Bionics's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Control Bionics Total Assets Chart

Control Bionics Annual Data
Trend Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Total Assets
Get a 7-Day Free Trial 18.14 13.44 8.70 9.03 8.23

Control Bionics Semi-Annual Data
Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.93 9.03 8.84 8.23 9.93

Control Bionics Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Control Bionics's Total Assets for the fiscal year that ended in Jun. 2025 is calculated as

Total Assets=Total Equity (A: Jun. 2025 )+Total Liabilities (A: Jun. 2025 )
=5.509+2.724
=8.23

Control Bionics's Total Assets for the quarter that ended in Dec. 2025 is calculated as

Total Assets=Total Equity (Q: Dec. 2025 )+Total Liabilities (Q: Dec. 2025 )
=7.729+2.204
=9.93

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of A$9.93 Mil mean?
Control Bionics (ASX:CBL) has a Total Assets of A$9.93 Mil as of Dec. 2025. The total amount of assets as recorded on a company's balance sheet. View historical data on Control Bionics and its competitors.
Is Control Bionics' Total Assets too high?
Control Bionics' current Total Assets is A$9.93 Mil.
How does Control Bionics' Total Assets compare to ABT and SYK?
Control Bionics' Total Assets of A$9.93 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Medical Devices & Instruments company?
A good Total Assets depends on the Medical Devices & Instruments industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Control Bionics and its competitors. Control Bionics's current Total Assets is A$9.93 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Control Bionics stock overvalued right now?
Based on GuruFocus' analysis, Control Bionics (ASX:CBL) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.03, compared to a current price of A$0.07 — trading 146.7% above its estimated fair value. The current Total Assets is A$9.93 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Control Bionics (ASX:CBL), the current Total Assets is A$9.93 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Control Bionics Business Description

Address 11-13 Pearson Street, Level 4, Cremorne, VIC, AUS, 3121
Control Bionics Ltd is engaged in the healthcare device business. It is involved in developing, commercializing, and selling assistive communications technology systems within the disability sector. Its core systems include NeuroNode Trilogy and NeuroNode3. These systems allow people with speech and movement difficulties to control a computer for speech generation, electronic communications, entertainment, and external control of other devices. Geographically, it derives a majority of revenue from North America and has its presence in Australia as well.